£120.99

Springer Malignant Lymphomas and Hodgkin's Disease Volume 66

Price data last checked 27 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£121 today · previous high £121 · all-time low £121

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 64 days • 64 data points (No recent data available)

Historical
Generating forecast...
£120.99 £120.71 £120.77 £120.84 £120.90 £120.96 £121.02 14 March 2026 29 March 2026 14 April 2026 30 April 2026 16 May 2026

Price Distribution

Price distribution over 64 days • 1 price levels

Days at Price
64 days 0 16 32 48 64 £121 Days at Price

Price Analysis

Most common price: £121 (64 days, 100.0%)

Price range: £121 - £121

Price levels: 1 different prices over 64 days

Description

Stay updated with the latest advancements in oncology with this specialized volume from the Cancer Treatment and Research series. Published by Springer, this book provides a wide selection of informative reviews focusing on malignant lymphomas, including Hodgkin's disease. As the understanding of lymphomagenesis grows, medical professionals need access to precise morphologic classification and new therapeutic insights. This text addresses the rapid expansion of knowledge in the field, covering the arrival of new cytotoxic and biologic therapeutic agents. It also examines modern drug delivery strategies that are changing how these diseases are treated. This volume is designed to help readers navigate the shift from old standard approaches to modern clinical practices. It serves as a comprehensive resource for those tracking the explosive growth of insight into the basic mechanisms of these diseases. Whether you are looking for updates on new drug developments or more accurate classification methods, this publication offers the detailed reviews necessary for modern medical practice.

Key Features

Comprehensive reviews on malignant lymphomas and Hodgkin's disease to assist in clinical understanding.

Updates on the rapid growth of insight regarding the basic mechanisms of lymphomagenesis.

Detailed information on new therapeutic agents, including both cytotoxic and biologic options.

Coverage of emerging drug delivery strategies to assist in modern treatment planning.

Focus on the need for precise morphologic classification in diagnosing these diseases.

Expert analysis of how new developments are changing traditional standard approaches.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research)
99% match

Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research)

Springer

£121.94 12 Jun 2026
Aggressive Lymphomas (Hematologic Malignancies)
98% match

Aggressive Lymphomas (Hematologic Malignancies)

Springer

£88.97 08 Mar 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
98% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£122.35 09 Mar 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
98% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£88.34 09 Mar 2026
Springer Hodgkin's and Non-Hodgkin's Lymphoma - Research Book
98% match

Springer Hodgkin's and Non-Hodgkin's Lymphoma - Research Book

Springer

£46.26 15 May 2026
Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)
98% match

Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)

Humana

£141.36 01 Mar 2026
Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)
97% match

Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)

Springer

£148.67 11 Jun 2026
Rare Lymphomas (Hematologic Malignancies)
97% match

Rare Lymphomas (Hematologic Malignancies)

Springer

£96.52 11 Jun 2026
Skin Lymphoma: The Illustrated Guide
97% match

Skin Lymphoma: The Illustrated Guide

Wiley-Blackwell

£100.68 23 Jan 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
97% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£291.99 11 Jan 2026
Saunders Extranodal Lymphomas: Expert Consult - Online and Print
97% match

Saunders Extranodal Lymphomas: Expert Consult - Online and Print

Saunders

£98.71 16 May 2026
Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)
97% match

Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)

Springer

£57.70 19 Apr 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
97% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£398.50 13 Jan 2026
Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)
97% match

Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)

Springer

£69.58 07 Mar 2026
Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)
97% match

Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)

Springer

£77.82 11 Mar 2026
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
97% match

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)

Springer

£91.64 25 Apr 2026
Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)
97% match

Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)

Humana

£117.00 28 Feb 2026
Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)
97% match

Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)

Springer

£77.39 11 Mar 2026
Lymphoma: Methods and Protocols: 2865 (Methods in Molecular Biology, 2865)
97% match

Lymphoma: Methods and Protocols: 2865 (Methods in Molecular Biology, 2865)

Humana

£135.00 30 May 2026
Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology
97% match

Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology

Humana

£101.00 18 Apr 2026
Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
97% match

Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)

Springer

£76.09 02 May 2026
Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
97% match

Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)

Springer

£65.04 28 Feb 2026
T-Cell and NK-Cell Lymphomas: From Biology to Novel Therapies: 176 (Cancer Treatment and Research, 176)
97% match

T-Cell and NK-Cell Lymphomas: From Biology to Novel Therapies: 176 (Cancer Treatment and Research, 176)

Springer

£107.85 02 May 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
97% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£244.99 14 Jan 2026